본문 바로가기

Hepatic resection for isolated stomach cancer liver metastases: A single-center experience

문서 유형
연구출판물 · 학술지 논문
등재
KCI
저널
대한종양외과학회지15(2) · pp.68 · 2019
피인용
KCI 0
ISSN
1738-8082

저자

  1. 김현유제1저자Pusan National University Hospital, Busan, Korea
  2. 서형일교신저자Pusan National University Hospital, Busan, Korea

초록

Purpose: The objective of this study was to investigate the outcomes of selected patients with stomach cancer liver metastasis (SCLM) without extrahepatic metastases after hepatic resection. Methods: Patients whose imaging results did not detect extrahepatic disease were selected for hepatic resection. If R0 resection was possible and if the operative risk was low in the preoperative tests, the patients underwent hepatic resection. Results: Between 2011 and 2016, seven patients underwent hepatic resection for SCLM. All patients received hepatic resection to achieve an R0 resection. Minor liver resection was performed in all patients. Two patients showed long-term survival with a single lesion and human epidermal growth factor receptor 2 (HER2)-negative tumor. The 5-year overall survival and disease-free survival rates after hepatic resection were 38.1% and 28.6%, respectively. Conclusion: Hepatic resection for isolated SCLM may be considered as a multimodality treatment. However, it has only limited benefits in select patients. It has long-term survival benefit in patients with single metastases and HER2-negative hormonal status.

키워드

Liver resectionLiver metastases

식별자

KCI
ART002549727